Summary & Overview
HCPCS G6034: Doxepin, Outpatient Medication
HCPCS Level II code G6034 designates Doxepin, a tricyclic antidepressant medication, billed in contexts where the drug is dispensed or administered in outpatient settings. Nationally, medications billed under HCPCS Level II codes matter for standardized reporting, Medicare administrative processing, and payer-specific coverage policies that affect access and reimbursement for pharmacologic therapies delivered outside inpatient facilities.
Key payers covered in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise briefing on the clinical context for Doxepin, the typical sites of service where billing occurs, and the types of benchmarks and policy considerations that commonly apply to HCPCS Level II drug billing. The full publication explores payer-specific coverage patterns, reimbursement benchmarks, applicable billing modifiers and service-line considerations, and implications for documentation and claims processing.
This material is intended to provide a national-level summary of the code’s purpose, payer coverage landscape, and the clinical and administrative topics readers should consult when coding and billing for Doxepin under HCPCS Level II G6034.
Billing Code Overview
HCPCS Level II code G6034 represents Doxepin, a tricyclic antidepressant medication used for indications such as depression, anxiety disorders, and certain dermatologic conditions (e.g., pruritus) depending on clinical context. The service type associated with G6034 is pharmacologic therapy / medication administration, and the typical site of service is outpatient pharmacy or outpatient clinic setting where the medication is dispensed or administered.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to a dermatology clinic or primary care office with chronic pruritus, atopic dermatitis, or insomnia with associated anxiety where a tricyclic antidepressant with antihistaminic properties is indicated. The clinician documents history, performs a focused skin or psychiatric exam, reviews medication history and cardiac risk factors (including current QT-prolonging agents), and orders baseline vitals. The provider prescribes G6034 (doxepin) for oral administration at a dose appropriate to the indication (low-dose for insomnia or itching, higher antidepressant doses for mood disorders). The prescription is transmitted to an outpatient pharmacy or, when applicable, the medication is dispensed from the facility’s outpatient pharmacy. Nursing staff provide counseling on sedation risk, anticholinergic effects, and avoidance of alcohol or other CNS depressants. Follow-up is scheduled to assess efficacy and side effects; ECG or laboratory monitoring is performed if clinically indicated (e.g., cardiac history, high dose). Billing uses the HCPCS Level II code G6034 for doxepin when required by payor reporting, with modifier use (for example TC for technical component where applicable) documented on the claim.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
TC |